Article metrics

Download PDFPDF
A phase III, randomized, double blinded trial of platinum based chemotherapy with or without atezolizumab followed by niraparib maintenance with or without atezolizumab in patients with recurrent ovarian, tubal, or peritoneal cancer and platinum treatment free interval of more than 6 months: ENGOT-Ov41/GEICO 69-O/ANITA Trial

 

Online download statistics by month:

Online download statistics by month: December 2020 to June 2024

AbstractFullPdf
Dec 20204213119
Jan 20212852113
Feb 20215182117
Mar 20215862413
Apr 202112603011
May 2021189149
Jun 2021735
Jul 20211153
Aug 20211178
Sep 20211138
Oct 202124045
Nov 202124362
Dec 202121011
Jan 202235866
Feb 202228112
Mar 202244835
Apr 202248467
May 202227252
Jun 202233377
Jul 202224252
Aug 202226479
Sep 2022294167
Oct 2022388510
Nov 202236157
Dec 202218813
Jan 202313388
Feb 202332888
Mar 2023285115
Apr 2023350312
May 202310144
Jun 202314116
Jul 202319362
Aug 2023222918
Sep 2023179118
Oct 2023359863
Nov 20233681735
Dec 2023417415
Jan 202429597
Feb 202435625
Mar 2024240918
Apr 202423657
May 202417359
Jun 202416784
Total12448345435